4-Bromoacetyl-3-fluorophenylboronic acid, 95.0%, 10g

(S)-(+)-NBD-APy [=(S)-(+)-4-Nitro-7-(3-aminopyrrolidin-1-yl)-2,1,3-benzoxadiazole] [HPLC Labeling Reagent for e.e. Determination]100mg

Methyl 2,5-dichloro-3-nitrobenzoate, 98+%, 10g

1-(3-Nitropyridin-2-yl)piperidine-4-carboxylic acid, 1g

3,5-dimethyl-1-propyl-1H-pyrazole-4-carbaldehyde, 95%, 10g

6-Fluoro-8-methylquinoline, 98%, 10g

(S)-2-Amino-3-methyl-1-morpholinobutan-1-one, 98%, 250mg

tert-Butyl 4-[3-(4-fluorophenyl)ureido]piperidine-1-carboxylate, 95.0%, 1g

2-(2,4-Dichlorophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95.0%, 25g

3-chloro-1,2,5-thiadiazole, 95.0%, 2.5g

2-(3-((3-Fluorobenzyl)oxy)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 250mg

3-CHLORO-1H-INDAZOLE-6-CARBOXYLIC ACID, 95%, 1g

1-Chloro-2,2-dimethylpropane>96.0%(GC)25mL